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Plasmacytoid dendritic cells (pDCs) play a major role in antiviral immunity via the
production of type I interferons (IFNs). There is some evidence that pDCs interact with
bacteria but it is not yet clear whether they are protective or contribute to bacterial
pathogenicity. We wished to investigate whether Coxiella burnetii, the agent of Q
fever, interacts with pDCs. The stimulation of pDCs with C. burnetii increased the
expression of activation and migratory markers (CD86 and CCR7) as determined by
flow cytometry and modulated gene expression program as revealed by a microarray
approach. Indeed, genes encoding for pro-inflammatory cytokines, chemokines, and
type I INF were up-regulated. The up-regulation of type I IFN was correlated with an
increase in IFN-α release by C. burnetii-stimulated pDCs. We also investigated pDCs in
patients with Q fever endocarditis. Using flow cytometry and a specific gating strategy,
we found that the number of circulating pDCs was significantly lower in patients with Q
fever endocarditis as compared to healthy donors. In addition, the remaining circulating
pDCs expressed activation and migratory markers. As a whole, our study identified
non-previously reported activation of pDCs by C. burnetii and their modulation during
Q fever.
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INTRODUCTION
Plasmacytoid dendritic cells (pDCs) are a subset of DCs present in the blood and lymphoid organs
and are well-documented as the major type I interferon (IFN)-producing cells (Cella et al., 1999;
Colonna et al., 2002). Their resting phenotype is characterized by the expression of chemokine
receptors such as CCR5, CXCR4, and microbe sensors including C-type lectins, TLR7, and TLR9.
Once activated, they overexpress two specific markers, CD86 (activation) and CCR7 (migratory
marker), and produce high levels of type I IFN and inflammatory cytokines (Siegal et al., 1999;
Facchetti et al., 2003; Liu, 2005; Martinelli et al., 2007; Gilliet et al., 2008). Plasmacytoid dendritic
cells specialize in innate antiviral immunity and are also involved in adaptive immunity (Liu, 2005;
Fiorentini et al., 2008). Type I IFNs are produced transiently by pDCs in acute viral infections
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and have a limited amplitude (Swiecki and Colonna, 2015).
Although produced by pDCs in chronic viral infections such
as those due to Human Immunodeficiency Virus (HIV; Bowie
and Unterholzner, 2008; Sachdeva et al., 2008), hepatitis C virus
(Mengshol et al., 2009), and hepatitis B virus (Xie et al., 2009),
the role of type I IFNs is more complex. Indeed, pDCs may
contribute to chronicity via the dysregulation of type I INF
production (Swiecki and Colonna, 2015).
In contrast to viral infections, the role of pDCs in the defense
against bacteria is poorly understood. There are few examples of
pDC maturation in response to bacteria in vitro. Streptococcus
pyogenes (Veckman and Julkunen, 2008) and Mycobacterium
tuberculosis (Lozza et al., 2014) increase the maturation of human
pDCs, leading to the activation of naive CD4+ T cells and Th1
polarization. The ability of pDCs to produce type I IFNs in
response to bacterial infections depends on the bacterial strain.
While Borrelia burgdorferi and Staphylococcus aureus induce the
production of type I IFNs by pDCs, S. pyogenes and Legionella
pneumophila do not (Veckman and Julkunen, 2008; Eberle et al.,
2009; Bekeredjian-Ding et al., 2014). In addition, pDCs may be
protective against bacterial infections. Hence, the depletion of
pDCs in a murine model of Chlamydia pneumoniae infection
results in severe and prolonged chronic inflammation (Crother
et al., 2012).
The presence of Coxiella burnetii, the bacterium responsible
for Q fever, within pDCs was recently reported in the lymph
nodes of patients with lymphomas (Melenotte et al., 2016).
This surprising observation led us to investigate the role of
pDCs in Q fever. Q fever is an infectious disease characterized
by a primary-infection which may become chronic in patients
with an altered immune response. The chronic expression of
the disease is dominated by endocarditis or vascular infection
(Raoult et al., 2005). Despite numerous studies, the mechanisms
of Q fever endocarditis and vascular infection remain partially
understood. We, and other teams, have reported the modulation
of circulating leukocytes, including monocyte and T cell subsets
(Ka et al., 2014, 2015), a non-protective inflammatory response
(Honstettre et al., 2003; Schoffelen et al., 2013) and the
prominent role of IL-10 in bacterial persistence and defective
microbicidal activity (Amara et al., 2012). Although, it is largely
admitted that monocytes and macrophages are the targets of
C. burnetii, there is evidence that other cell types, including
DCs, may host the microorganisms (Shannon et al., 2005). We
recently showed that C. burnetii activates human monocyte-
derived dendritic cells (moDCs), inducing a transcriptional
inflammatory program in which the type I IFN pathway is
impaired (Gorvel et al., 2014). However, the interaction of
C. burnetii with other DC populations has not yet been
reported.
In this report, we show that C. burnetii induces a migratory
phenotype and a specific inflammatory signature in pDCs.
Coxiella burnetii also stimulates the release of type I IFNs.
In addition, the number of circulating pDCs was lower in
patients with Q fever endocarditis. Taken as a whole, the present
study shows that pDCs are involved in C. burnetii infection
and identifies a new feature of the immune response in Q
fever.
MATERIALS AND METHODS
Patients with Q Fever Endocarditis
The study of 17 patients with Q fever endocarditis (consisting
of six women and eleven men aged between 22 and 79 years
old) and their controls was conducted with the approval of
the Ethics Committee of Aix-Marseille University (Marseille,
France) and with the written consent of each participant. The
characteristics of the patients were previously described (Ka
et al., 2014). Seventeen patients with Q fever endocarditis were
included on the basis of the presence of endocarditis, a positive
echocardiogram and blood culture, high titers of IgG specific for
phase I C. burnetii and data scoring (Raoult, 2012). Ten age- and
sex-matched individuals were included as healthy controls.
Bacteria Production and Preparation
Coxiella burnetii (Nine Mile strain, RSA496) was cultured as
previously described (Gorvel et al., 2014). The L929 cells were
infected for 8 days and were sonicated and centrifuged at 300
× g for 10 min. Supernatants were collected and centrifuged at
10,000 × g for 10 min. Bacteria were then washed and stored
at −80◦C. The concentration of organisms was determined by
Gimenez staining and bacterial viability was assessed using the
LIVE/DEAD BacLight bacterial viability kit (Molecular Probes,
Life Technologies).
pDC Isolation and Stimulation
Leukopacks were obtained from the Etablissement Français
du Sang. Peripheral blood mononuclear cells (PBMCs) were
recovered using density gradient centrifugation. The pDCs were
isolated usingmagnetic beads on AutoMacs (Miltenyi Biotech) as
previously described (Ka et al., 2014). Briefly, pDCs were isolated
by depletion of non-pDCs that were retained in the column, while
unlabeled pDCs with high purity (90%) were collected in the
flow-through. Plasmacytoid dendritic cells were then suspended
in RPMI 1640, supplemented with 20 mM HEPES, 10% fetal
calf serum, 2 mM L-glutamine, 100 U penicillin/ml, 50 µg/ml
streptomycin (Life Technologies), and 10 ng/ml recombinant IL-
3 (R&D Systems), as described previously (Dental et al., 2012)
and were stimulated with heat-inactivated (100◦C for 30 min) C.
burnetii organisms (bacterium-to-cell ratio of 50:1), or CpG-A 10
µg/mL (ODN 2216; InvivoGen) for 8 or 24 h.
Flow Cytometry
Flow cytometry was used to study isolated pDCs within PBMCs.
First, isolated pDCs were analyzed according to the expression
of activation (CD86) and maturation (CCR7) markers. In brief,
after stimulation, isolated-pDCs were washed and then incubated
with CD86 or CCR7 antibodies or isotypic controls for 20
min. After fixation with 4% paraformaldehyde, the expression
of markers was evaluated by flow cytometry. Second, PBMCs
from patients with Q fever endocarditis or healthy controls were
incubated with specific antibodies or isotypic controls and Aqua-
Fluorescent Reactive dye (Aqua-vivid), a viability dye, for 20 min
(Supplementary Table 1). PBMCs were then washed and fixed in
4% paraformaldehyde. Flow cytometry was performed using an
LSRII-SORP cytometer (Becton Dickinson). After 500,000 events
had been completed and debris on the forward/side scatter dot
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plot and dead cells had been excluded with Aqua-Fluorescent
Reactive dye, data were exported and analyzed with FlowJo
Software (version 9.2, Tree Star Ashland) (Ka et al., 2014). The
proportion of pDCs is expressed as the ratio of living cells
expressing the fluorescent marker to the total number of analyzed
PBMCs. The phenotypic expression of HLA-DR and PD-1 is
expressed as the mean fluorescence intensity (MFI).
Microarrays
Isolated pDCs were stimulated with heat-inactivated C. burnetii
for 8 h. RNA was extracted using RNeasy Mini Kits (Qiagen)
with a DNase I step to eliminate DNA contaminants, as
previously described (Gorvel et al., 2014). The quantity
and quality of the RNA was assessed using a Nanodrop
spectrophotometer (Thermo Science) and a 2100 Bioanalyzer
(Agilent Technologies), respectively. The microarray study
was performed using the technology provided by Agilent
Technologies, consisting of microarray chips including 45,000
probes (4x44K Whole Human Genome G4112F) and One-
Color Microarray-Based Gene Expression Analysis. In brief,
400 ng RNA were labeled with cyanine-3 CTP using a Low
RNA Input Fluorescent Amplification kit. Three biological
replicates per group were labeled using a QIAamp labeling kit,
deposited on microarray slides, and hybridized for 17 h at
65◦C. The microarray slides were scanned with a pixel size of
5 µm using a DNA Microarray scanner G2505B. The scanned
images were analyzed with Feature Extraction Software 10.5.1.
The data processing and analysis were performed using the R
software package (version 2.15). The raw data were filtered and
normalized using the Agi4x44 PreProcess library. Unsupervised
and supervised analyses were performed using hierarchical
clustering and a principal component analysis. Genes were
considered to be differentially expressed if the False Discovery
Rate was below 0.1% and the absolute fold change was above 2.0
(Gorvel et al., 2014).
Quantitative Real Time-Polymerase Chain
Reaction (qRT-PCR)
Specific genes of stimulated pDCs that were found to be highly
modulated by microarray were selected and validated by qRT-
PCR, as previously described (Ben Amara et al., 2013). Briefly,
first-strand cDNA was obtained using oligo(dT) primers and a
reverse transcription of 150 ng RNA using a Moloney murine
leukemia virus-reverse transcriptase kit (Life Technologies), a
ABI7900 Fast Real-Time PCR System, and a SYBR Green Fast
Master Mix (Roche Diagnostics). The results were normalized
to the housekeeping gene β-actin (ACTB) and were expressed as
the median of fold change= 2−11Ct, where11Ct= (CtTarget −
CtActin)assay − (CtTarget − CtActin)control, as previously described
(Ben Amara et al., 2010).
Immunoassays
Isolated pDCs were stimulated with heat-inactivated C. burnetii
organisms for 24 h, and the supernatants were centrifuged at
1000 × g for 10min and frozen at −80◦C. In parallel, PBMCs
from healthy controls and Q fever patients were cultivated for
24 h and supernatants were treated as above. The release of IFN-
α, IL-6, TNF-α, and IL-10 was determined using immunoassay
kits. The concentration of IL-10 and IFN-α in patients was also
analyzed by immunoassay.
Statistical Analysis
Data were analyzed using the Student’s t-test to analyze in vitro
data and the Mann–Whitney U-test to study Q fever patients.
The results are presented as the median or the mean ± SD of
three independent experiments, and a p < 0.05 was considered
statistically significant.
RESULTS
Coxiella burnetii Stimulates Human pDCs
We wanted to investigate whether C. burnetii interacts with
human pDCs. Living pDCs were isolated from the PBMCs
of healthy donors and the expression of BDCA2 and CD123,
two specific markers of pDCs, was determined by flow
cytometry (Figure 1A). After 24 h of stimulation by C.
burnetii, the expression of the migratory marker CCR7 and the
activation marker CD86 significantly increased as compared to
unstimulated pDCs although their expression remained lower
than that of pDCs activated with CpG-A used as positive control
(Figure 1B), demonstrating that pDCs responded to C. burnetii
stimulation. We completed the investigation of the response
of pDCs to C. burnetii using an unbiased approach based on
transcriptome study with three biological replicates per group.
Coxiella burnetii induced a gene expression program which was
clearly distinct from that of resting pDCs, as shown by principal
component analysis (Figure 1C, left panel) and hierarchical
clustering (Figure 1C, right panel). Usingmulticlass analysis and
a fold change of 2.0, we found that 1109 probes were up-regulated
and 665 were down-regulated after 8 h of stimulation with C.
burnetii. The functional annotation enabled keywords enriched
in C. burnetii-stimulated pDCs to be identified (Table 1). They
included an inflammatory response (enrichment score of 17.83),
pathogen sensing (enrichment score of 9.93), and a regulation
of cell proliferation (enrichment score of 5.63) in up-regulated
genes. We selected the genes encoding for IL-6, IL-1β, IL-15, and
CD40 because they were highly up-regulated in microarray and
we confirmed their over-expression by qRT-PCR (Figure 1D).
Taken together, these results show that C. burnetii highly
stimulates human pDCs.
Coxiella burnetii Stimulates Inflammatory
Response in pDCs
As inflammatory genes were modulated in C. burnetii-stimulated
pDCs, we investigated the secretion by pDCs of TNF-α and IL-
6, two cytokines considered as inflammatory cytokines. Coxiella
burnetii induced the release of TNF-α but not that of IL-6.
Surprisingly, C. burnetii stimulated the release of IL-10, an
anti-inflammatory cytokine (Figure 2A), demonstrating subtle
changes in the inflammatory response of pDCs to C. burnetii. In
the microarray signature, two keywords, namely “inflammatory
response” and “pathogen sensing” were enriched in C. burnetii-
stimulated pDCs; they included genes encoding cytokines and
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FIGURE 1 | Coxiella burnetii modulates an inflammatory response of pDCs. (A) Flow cytometer graphs showing the gating strategy to study pDCs. (B) CCR7
and CD86 expression of isolated pDCs stimulated (C. burnetii) or not (control) with heat-inactivated C. burnetii or CpG-A (10 µg/ml) during 24 h were visualized (left
panel) and quantified (right panel) by flow cytometer. (C) A microarray approach allowed to show the degree of the variation of gene expression (C, left panel), the
transcriptional signature (C, right panel) and the modulated genes of pDCs stimulated (C. burnetii) or not (control) with heat-inactivated C. burnetii during 8 h. The
microarray was conducted with three biological replicates. (D) Representative graph evaluating the fold change of IL-6, IL-1b, IL-15, and CD40 genes using the
microarray or the qRT-PCR approach were effected and statistically analyzed on the basis of the Ct-values. The results are the means ± SD of three independent
experiments. **p < 0.01 and ***p < 0.001.
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TABLE 1 | Up-regulated genes of pDCs-stimulated by C. burnetii.
Keywords P-values
INFLAMMATORY RESPONSE (ES: 17.83-463 genes; INFA, INFB1, INFE,
IL1A, IL1B, TNF, IL-6, IL28A, IL28B, IL-29, IL12A, IL12B, IL13, IL15, IL8,
CCL2, CCL8, CCL8, CXCL2, CXCL9)
Cytokine activity 1.2 × 10−37
Cytokine cytokine receptor interaction 4.0 × 10−28
Immune response 1.9 × 10−24
Defense response 7.8 × 10−21
Inflammatory response 1.1 × 10−12
PATHOGEN SENSING (ES: 9.93-80 genes; INFA, INFB, INFE, IL1B, IL28A,
IL28B, IL-29, IL12A, IL12B, IL-6, IL8, IL13, IL15, TNF, CCL4, CCL10,
CCL10, CXCL9, CXCL11)
RIG-I-like receptor signaling pathway 5.5 × 10−18
Toll-like receptor signaling pathway 2.4 × 10−17
Jak-STAT signaling pathway 1.6 × 10−15
Cytosolic DNA-sensing pathway 8.4 × 10−12
REGULATION OF CELL PROLIFERATION (ES: 5.63-88 genes; CD38,
CD40, TNF, IL1B, IL4, IL6, IL13, IL15, IL12A, IL12B, IL2R)
Positive regulation of lymphocytes proliferation 4.9 × 10−10
Positive regulation of leukocytes proliferation 6.1 × 10−10
Positive regulation of mononuclear cells proliferation 6.1 × 10−10
Positive regulation of lymphocytes proliferation 3.7 × 10−9
Regulation of lymphocytes proliferation 4.0 × 10−9
Regulation of lymphocytes proliferation 4.6 × 10−9
Regulation of apoptosis 1.5 × 10−7
Regulation of programmed death 1.9 × 10−7
Regulation of death cells 2.0 × 10−7
Anti-apoptosis 1.5 × 10−5
Negative regulation of apoptosis 9.9 × 10−5
Negative regulation of programmed death 1.1 × 10−4
Identification of three clusters defined as: Inflammatory response, Pathogens sensing, and
regulation of cell proliferation.
chemokines and type I and III IFNs (IFN-α, IFN-β1, and IFN-
ε) with a fold change higher than 15 (Table 1). As IFN-α was
documented as a cytokine specifically expressed by pDCs, we
measured its release in supernatants from pDCs stimulated (or
not) with C. burnetii or CpG-A, a potent agonist of pDCs. While
resting pDCs did not release IFN-α, C. burnetii-stimulated pDCs
released ∼1.5 ng/ml IFN-α (Figure 2B), demonstrating that C.
burnetii stimulated type I IFN expression at both transcriptional
and transductional levels. Taken together, these results showed
that C. burnetii affected the inflammatory response of pDCs and
particularly the IFN-α response.
Circulating pDCs Are Affected in Patients
with Q Fever Endocarditis
As pDCs are activated in vitro by C. burnetii, we wanted
to investigate whether they are modulated in patients during
Q fever endocarditis. We investigated the pDC population in
blood samples from healthy donors (n = 10) and Q fever
endocarditis patients (n= 17). Using flow cytometry and a gating
strategy with specific antibodies (Supplementary Table 1), we
were able to discriminate between living pDCs and mDC2
within PBMCs (Supplementary Figure 1). The number of pDCs
decreased by 30% in patients with Q fever endocarditis as
compared to controls (Figure 3A, up panel). In contrast, the
percentage of mDC2 was higher in patients with Q fever
endocarditis (Figure 3A, down panel), demonstrating that pDCs
were specifically affected by C. burnetii infection. We also found
that the phenotypic characteristics of pDCs were affected in Q
fever endocarditis. Indeed, the expression of activation markers
HLA-DR (Figure 3B, up panel) and PD-1 (Figure 3C, up panel)
was increased in pDCs from patients with Q fever endocarditis.
It should be noted that only PD-1 increased in mDC2 from the
same patients (Figures 3B,C, down panels). Finally, we studied
the spontaneous release of IFN-α by PBMCs from patients with
Q fever endocarditis. We found that the release of IFN-α was
markedly depressed in patients compared with healthy controls
(Figure 3D, right panel), which is likely to be because the
number of circulating pDCs was low. The release of IL-10 was
increased in patients with Q fever endocarditis (Figure 3D, left
panel), in accordance with previous results (Capo et al., 1996).
Taken together, these results showed that the number of pDCs
was depressed in patients with Q fever endocarditis and that the
remaining pDCs exhibited specific features of activation.
DISCUSSION
In this study, we report, for the first time, the ability of C.
burnetii to activate human pDCs in vitro. Indeed, they expressed
CCR7 and CD86, migratory and activation markers, respectively.
CCR7 plays a role in the migration of pDCs from blood to
T cell areas of the lymph nodes and the white pulp of the
spleen (Swiecki and Colonna, 2015). Using a high throughput
microarray approach, we showed that C. burnetii modulated
the expression of a large number of genes in which keywords
including “inflammatory response,” “pathogen sensing,” and
“regulation of cell proliferation” were enriched. We showed that
C. burnetii stimulated the production of IFN-α associated with
the release of TNF-α and IL-10, suggesting a modulation of
inflammatory response to the pathogen.
Interestingly, transcriptomic analysis revealed the up-
regulation of genes that could be involved in the type I IFN
pathway. First, genes enriched in the keyword “pathogen
sensing,” such as TLR7 and signaling molecules such as MyD88
and IRF7, were up-regulated in C. burnetii-stimulated pDCs.
The overexpression of TLR7 and TLR9 with the IRF7 gene are
necessary for type I IFN production by pDCs, suggesting that
this pathway may play a role in pDCs’ response to C. burnetii
(Kawai and Akira, 2010; Trinchieri, 2010). Secondly, the RNA
helicase retinoic acid-inducible gene I (RIG-I) was up-regulated
in C. burnetii-stimulated pDCs. RIG-I is a cytoplasmic receptor
known to be responsible for triggering type I IFN secretion
(Pandey et al., 2009; Kawai and Akira, 2010). Thirdly, C.
burnetii up-regulated the expression of the genes encoding the
nucleotide-binding oligomerization domain-containing protein
(NOD)-1 and NOD2 receptors, which may be involved in the
production of type I IFN (Pandey et al., 2009; Watanabe et al.,
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FIGURE 2 | Coxiella burnetii induces an interferon-like response by pDCs. TNF-α (left panel), IL-6 (middle panel), IL-10 (right panel) (A) and IFN-a (B) were
quantified by ELISA immunoassay in supernatants of purified pDCs stimulated with heat-inactivated C. burnetii (C. burnetii) or not (control) during 24 h. The results are
the means ± SD of three independent experiments. *p < 0.05 and ***p < 0.001.
2010). Indeed, M. tuberculosis induces type I IFN production
through the activation of NOD2 in macrophages (Pandey et al.,
2009) and Helicobacter pylori through NOD1 in epithelial cells
(Watanabe et al., 2010). In addition, Neisseria meningitidis,
Hemophilus influenza, and S. aureus were found to stimulate
the secretion of IFN-α and to increase the expression of CD86
on pDCs (Michea et al., 2013). The production of IFN-α by
C. burnetii-stimulated pDCs associated with the activation
phenotype is distinct from the response to S. pyogenes in which
IFN-α is not produced (Veckman and Julkunen, 2008) and from
the M. tuberculosis response in which the activation markers are
lacking (Lozza et al., 2014).
As C. burnetii induced a specific response in pDCs in vitro,
we questioned whether circulating pDCs are affected in Q fever.
We showed that pDCs were decreased in patients with Q fever
endocarditis. We studied patients with Q fever endocarditis and
not patients with chronic Q fever since this concept is debated
among teams involved in Q fever investigation. In addition,
preliminary results showed that patients with primary infection
also exhibited decreased amounts of circulating pDCs (data not
shown). To our knowledge, this is the first report demonstrating
the modulation of the number of circulating pDCs in Q fever.
We do not know whether the decrease in circulating pDCs
reflects their migration to tissues nor the nature of their role in
resistance or susceptibility to C. burnetii. The role of pDCs in the
defense against bacteria is only supported by a report in which
the depletion of pDCs increases the virulence of C. pneumonia
in mice (Crother et al., 2012). Plasmacytoid dendritic cells are
protective in viral infections. The number of circulating pDCs is
reduced in patients who are chronically infected with hepatitis
B virus, hepatitis C virus and HIV (Goutagny et al., 2004;
Ulsenheimer et al., 2005; Meyers et al., 2007). This decrease is
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FIGURE 3 | Plasmacytoid dendritic cells are affected in Q fever patients. Plasmacytoid dendritic cells from healthy controls (n = 10) and patients with Q fever
endocarditis (n = 17) were analyzed and quantified by flow cytometry and Elisa. (A) Graphs showing the percentage of living cells, of (B) HLA-DR and (C) PD-1
expression of mDC2 and pDCs in the population studied. (D) Quantitative graphs of IL-10 (left panel) and IFN-a (right panel) were evaluated in Q fever endocarditis
patients and healthy donors. The non-parametric Mann-Whitney U-test was used to compare patient and control groups. *p < 0.05 and **p < 0.01. Horizontal bar,
median value.
correlated with a high viral load (Soumelis et al., 2001; Gurney
et al., 2004). Interestingly, patients treated with highly active
anti-retroviral therapy are marked by a decreased viral load
and an increased number of circulating pDCs, suggesting this
cell population is involved in the control of HIV infection
(Pacanowski et al., 2001; Keir et al., 2002).
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We also showed that circulating pDCs were likely to be
activated in Q fever. Indeed, they over-expressed HLA-DR and
PD-1. This pattern was not specific since it was also found in
mDC2 from patients with Q fever endocarditis. The activated
phenotype of pDCs in patients with Q fever may account for
the increased traffic of pDCs from blood to peripheral tissues.
The increased in vitro expression of a migratory marker such as
CCR7 in response to C. burnetii may account for greater traffic
to tissues. We recently showed that pDCs are present in the
lymph nodes from Q fever lymphomas and are infected with C.
burnetii (Melenotte et al., 2016). This suggests that C. burnetii
infection may encourage the traffic of pDCs to lymph nodes. We
also observed that patients with Q fever endocarditis exhibited
a decrease in IFN-α production by PBMCs. We hypothesized
that the decrease in IFN-α production is related to decrease
levels of circulating pDCs. Whether IFN-α is involved in the
pathophysiology of Q fever will require additional experiments.
In conclusion, we demonstrated that C. burnetii induced
a strong inflammatory response in pDCs in which type I
IFN was specifically enriched. The present study described
a new feature of the immune response in Q fever and
also suggested the importance of pDCs in chronic bacterial
infections.
AUTHOR CONTRIBUTIONS
Performed the experiments: MK, SM, and AB. Analyzed the data
and wrote the paper: DR, JM, DO, EG, and AB.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fcimb.
2016.00070
Supplementary Figure 1 | Gating strategy to study pDC population (A)
Representative graphs showing the gating strategy of pDCs identification
by flow cytometry.
Supplementary Table 1 | List of fluorescent reagents used in this study.
(AF, Alexa fluor; APC, Allophycocyanin; ECD, Phycoerythrin-texas red, FITC,
Fluorescein isothiocyanate; PB, Pacific blue; PC, Phycoerythrin; PerCP-Cy5.5,
Peridinin chlorophyll protein-cyanin 5.5; and PE, Phycoerythrin).
REFERENCES
Amara, A. B., Bechah, Y., and Mege, J.-L. (2012). Immune response and Coxiella
burnetii invasion. Adv. Exp. Med. Biol. 984, 287–298. doi: 10.1007/978-94-007-
4315-1_15
Bekeredjian-Ding, I., Greil, J., Ammann, S., and Parcina, M. (2014). Plasmacytoid
dendritic cells: neglected regulators of the immune response to Staphylococcus
aureus. Front. Immunol. 5:238. doi: 10.3389/fimmu.2014.00238
Ben Amara, A., Ghigo, E., Le Priol, Y., Lépolard, C., Salcedo, S. P., Lemichez,
E., et al. (2010). Coxiella burnetii, the agent of Q fever, replicates within
trophoblasts and induces a unique transcriptional response. PLoS ONE
5:e15315. doi: 10.1371/journal.pone.0015315
Ben Amara, A., Gorvel, L., Baulan, K., Derain-Court, J., Buffat, C., Vérollet,
C., et al. (2013). Placental macrophages are impaired in chorioamnionitis,
an infectious pathology of the placenta. J. Immunol. 191, 5501–5514. doi:
10.4049/jimmunol.1300988
Bowie, A. G., and Unterholzner, L. (2008). Viral evasion and subversion of
pattern-recognition receptor signalling. Nat. Rev. Immunol. 8, 911–922. doi:
10.1038/nri2436
Capo, C., Zaffran, Y., Zugun, F., Houpikian, P., Raoult, D., and Mege, J. L. (1996).
Production of interleukin-10 and transforming growth factor beta by peripheral
bloodmononuclear cells in Q fever endocarditis. Infect. Immun. 64, 4143–4147.
Cella, M., Jarrossay, D., Facchetti, F., Alebardi, O., Nakajima, H., Lanzavecchia,
A., et al. (1999). Plasmacytoid monocytes migrate to inflamed lymph nodes
and produce large amounts of type I interferon. Nat. Med. 5, 919–923. doi:
10.1038/11360
Colonna, M., Krug, A., and Cella, M. (2002). Interferon-producing cells: on the
front line in immune responses against pathogens. Curr. Opin. Immunol. 14,
373–379. doi: 10.1016/S0952-7915(02)00349-7
Crother, T. R., Ma, J., Jupelli, M., Chiba, N., Chen, S., Slepenkin, A., et al. (2012).
Plasmacytoid dendritic cells play a role for effective innate immune responses
during Chlamydia pneumoniae infection in mice. PLoS ONE 7:e48655. doi:
10.1371/journal.pone.0048655
Dental, C., Florentin, J., Aouar, B., Gondois-Rey, F., Durantel, D., Baumert,
T. F., et al. (2012). Hepatitis C virus fails to activate NF-κB signaling in
plasmacytoid dendritic cells. J. Virol. 86, 1090–1096. doi: 10.1128/JVI.05
444-11
Eberle, F., Sirin, M., Binder, M., and Dalpke, A. H. (2009). Bacterial RNA
is recognized by different sets of immunoreceptors. Eur. J. Immunol. 39,
2537–2547. doi: 10.1002/eji.200838978
Facchetti, F., Vermi, W., Mason, D., and Colonna, M. (2003). The plasmacytoid
monocyte/interferon producing cells. Virchows Arch. Int. J. Pathol. 443,
703–717. doi: 10.1007/s00428-003-0918-8
Fiorentini, S., Riboldi, E., Facchetti, F., Avolio, M., Fabbri, M., Tosti, G., et al.
(2008). HIV-1 matrix protein p17 induces human plasmacytoid dendritic cells
to acquire a migratory immature cell phenotype. Proc. Natl. Acad. Sci. U.S.A.
105, 3867–3872. doi: 10.1073/pnas.0800370105
Gilliet, M., Cao, W., and Liu, Y.-J. (2008). Plasmacytoid dendritic cells: sensing
nucleic acids in viral infection and autoimmune diseases.Nat. Rev. Immunol. 8,
594–606. doi: 10.1038/nri2358
Gorvel, L., Textoris, J., Banchereau, R., Ben Amara, A., Tantibhedhyangkul, W.,
von Bargen, K., et al. (2014). Intracellular bacteria interfere with dendritic
cell functions: role of the type I interferon pathway. PLoS ONE 9:e99420. doi:
10.1371/journal.pone.0099420
Goutagny, N., Vieux, C., Decullier, E., Ligeoix, B., Epstein, A., Trepo, C., et al.
(2004). Quantification and functional analysis of plasmacytoid dendritic cells in
patients with chronic hepatitis C virus infection. J. Infect. Dis. 189, 1646–1655.
doi: 10.1086/383248
Gurney, K. B., Colantonio, A. D., Blom, B., Spits, H., and Uittenbogaart, C.
H. (2004). Endogenous IFN-alpha production by plasmacytoid dendritic
cells exerts an antiviral effect on thymic HIV-1 infection. J. Immunol. 173,
7269–7276. doi: 10.4049/jimmunol.173.12.7269
Honstettre, A., Imbert, G., Ghigo, E., Gouriet, F., Capo, C., Raoult, D., et al. (2003).
Dysregulation of cytokines in acute Q fever: role of interleukin-10 and tumor
necrosis factor in chronic evolution of Q fever. J. Infect. Dis. 187, 956–962. doi:
10.1086/368129
Ka, M. B., Gondois-Rey, F., Capo, C., Textoris, J., Million, M., Raoult, D., et al.
(2014). Imbalance of circulatingmonocyte subsets and PD-1 dysregulation in Q
fever endocarditis: the role of IL-10 in PD-1 modulation. PLoS ONE 9:e107533.
doi: 10.1371/journal.pone.0107533
Ka, M. B., Gondois-Rey, F., Ghigo, E., Raoult, D., Olive, D., and Mege, J.-L. (2015).
Imbalance of circulating lymphoid cells in Q fever endocarditis. Pathog. Dis. 73,
1–3. doi: 10.1093/femspd/ftu010
Kawai, T., and Akira, S. (2010). The role of pattern-recognition receptors in innate
immunity: update on Toll-like receptors. Nat. Immunol. 11, 373–384. doi:
10.1038/ni.1863
Keir, M. E., Stoddart, C. A., Linquist-Stepps, V., Moreno, M. E., and McCune,
J. M. (2002). IFN-alpha secretion by type 2 predendritic cells up-regulates
MHC class I in the HIV-1-infected thymus. J. Immunol. 168, 325–331. doi:
10.4049/jimmunol.168.1.325
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 8 June 2016 | Volume 6 | Article 70
Ka et al. Plasmacytoid Dendritic Cells in Q Fever
Liu, Y.-J. (2005). IPC: professional type 1 interferon-producing cells and
plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23, 275–306. doi:
10.1146/annurev.immunol.23.021704.115633
Lozza, L., Farinacci, M., Faé, K., Bechtle, M., Stäber, M., Dorhoi, A., et al.
(2014). Crosstalk between human DC subsets promotes antibacterial activity
and CD8+ T-cell stimulation in response to bacille Calmette-Guérin. Eur. J.
Immunol. 44, 80–92. doi: 10.1002/eji.201343797
Martinelli, E., Cicala, C., Van Ryk, D., Goode, D. J., Macleod, K., Arthos, J.,
et al. (2007). HIV-1 gp120 inhibits TLR9-mediated activation and IFN-{alpha}
secretion in plasmacytoid dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 104,
3396–3401. doi: 10.1073/pnas.0611353104
Melenotte, C., Million, M., Audoly, G., Gorse, A., Dutronc, H., Roland, G., et al.
(2016). B-cell non-Hodgkin lymphoma linked to Coxiella burnetii. Blood 127,
113–121. doi: 10.1182/blood-2015-04-639617
Mengshol, J. A., Golden-Mason, L., Castelblanco, N., Im, K. A., Dillon, S. M.,
Wilson, C. C., et al. (2009). Impaired plasmacytoid dendritic cell maturation
and differential chemotaxis in chronic hepatitis C virus: associations with
antiviral treatment outcomes. Gut 58, 964–973. doi: 10.1136/gut.2008.1
68948
Meyers, J. H., Justement, J. S., Hallahan, C. W., Blair, E. T., Sun, Y.
A., O’Shea, M. A., et al. (2007). Impact of HIV on cell survival and
antiviral activity of plasmacytoid dendritic cells. PLoS ONE 2:e458. doi:
10.1371/journal.pone.0000458
Michea, P., Vargas, P., Donnadieu, M.-H., Rosemblatt, M., Bono, M. R., Duménil,
G., et al. (2013). Epithelial control of the human pDC response to extracellular
bacteria. Eur. J. Immunol. 43, 1264–1273. doi: 10.1002/eji.201242990
Pacanowski, J., Kahi, S., Baillet, M., Lebon, P., Deveau, C., Goujard, C.,
et al. (2001). Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid)
dendritic cell numbers in primary HIV-1 infection. Blood 98, 3016–3021. doi:
10.1182/blood.V98.10.3016
Pandey, A. K., Yang, Y., Jiang, Z., Fortune, S. M., Coulombe, F., Behr, M.
A., et al. (2009). NOD2, RIP2 and IRF5 play a critical role in the type I
interferon response to Mycobacterium tuberculosis. PLoS Pathog. 5:e1000500.
doi: 10.1371/journal.ppat.1000500
Raoult, D. (2012). Chronic Q fever: expert opinion versus literature analysis and
consensus. J. Infect. 65, 102–108. doi: 10.1016/j.jinf.2012.04.006
Raoult, D., Marrie, T., and Mege, J. (2005). Natural history and pathophysiology
of Q fever. Lancet Infect. Dis. 5, 219–226. doi: 10.1016/S1473-3099(05)
70052-9
Sachdeva, N., Asthana, V., Brewer, T. H., Garcia, D., and Asthana, D. (2008).
Impaired restoration of plasmacytoid dendritic cells in HIV-1-infected patients
with poor CD4 T cell reconstitution is associated with decrease in capacity
to produce IFN-alpha but not proinflammatory cytokines. J. Immunol. 181,
2887–2897. doi: 10.4049/jimmunol.181.4.2887
Schoffelen, T., Joosten, L. A. B., Herremans, T., de Haan, A. F. J., Ammerdorffer, A.,
Rümke, H. C., et al. (2013). Specific interferon γ detection for the diagnosis of
previous Q fever. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 56, 1742–1751.
doi: 10.1093/cid/cit129
Shannon, J. G., Howe, D., and Heinzen, R. A. (2005). Virulent Coxiella
burnetii does not activate human dendritic cells: role of lipopolysaccharide
as a shielding molecule. Proc. Natl. Acad. Sci. U.S.A. 102, 8722–8727. doi:
10.1073/pnas.0501863102
Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho,
S., et al. (1999). The nature of the principal type 1 interferon-producing cells in
human blood. Science 284, 1835–1837. doi: 10.1126/science.284.5421.1835
Soumelis, V., Scott, I., Gheyas, F., Bouhour, D., Cozon, G., Cotte, L., et al.
(2001). Depletion of circulating natural type 1 interferon-producing cells in
HIV-infected AIDS patients. Blood 98, 906–912. doi: 10.1182/blood.V98.4.906
Swiecki, M., and Colonna, M. (2015). The multifaceted biology of plasmacytoid
dendritic cells. Nat. Rev. Immunol. 15, 471–485. doi: 10.1038/nri3865
Trinchieri, G. (2010). Type I interferon: friend or foe? J. Exp. Med. 207, 2053–2063.
doi: 10.1084/jem.20101664
Ulsenheimer, A., Gerlach, J. T., Jung, M.-C., Gruener, N., Wächtler, M., Backmund,
M., et al. (2005). Plasmacytoid dendritic cells in acute and chronic hepatitis C
virus infection. Hepatology 41, 643–651. doi: 10.1002/hep.20592
Veckman, V., and Julkunen, I. (2008). Streptococcus pyogenes activates human
plasmacytoid and myeloid dendritic cells. J. Leukoc. Biol. 83, 296–304. doi:
10.1189/jlb.0707457
Watanabe, T., Asano, N., Fichtner-Feigl, S., Gorelick, P. L., Tsuji, Y., Matsumoto,
Y., et al. (2010). NOD1 contributes to mouse host defense against Helicobacter
pylori via induction of type I IFN and activation of the ISGF3 signaling pathway.
J. Clin. Invest. 120, 1645–1662. doi: 10.1172/JCI39481
Xie, Q., Shen, H.-C., Jia, N.-N., Wang, H., Lin, L.-Y., An, B.-Y., et al. (2009).
Patients with chronic hepatitis B infection display deficiency of plasmacytoid
dendritic cells with reduced expression of TLR9. Microbes Infect. Inst. Pasteur
11, 515–523. doi: 10.1016/j.micinf.2009.02.008
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Ka, Mezouar, Ben Amara, Raoult, Ghigo, Olive and Mege. This
is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) or licensor are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 9 June 2016 | Volume 6 | Article 70
